Cargando…
Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy.
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1975
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024885/ https://www.ncbi.nlm.nih.gov/pubmed/1061614 |
_version_ | 1782136651305189376 |
---|---|
author | Taylor, G. M. Harris, R. Freeman, C. B. |
author_facet | Taylor, G. M. Harris, R. Freeman, C. B. |
author_sort | Taylor, G. M. |
collection | PubMed |
description | |
format | Text |
id | pubmed-2024885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1975 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20248852009-09-10 Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy. Taylor, G. M. Harris, R. Freeman, C. B. Br J Cancer Research Article Nature Publishing Group 1975-08 /pmc/articles/PMC2024885/ /pubmed/1061614 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Taylor, G. M. Harris, R. Freeman, C. B. Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy. |
title | Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy. |
title_full | Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy. |
title_fullStr | Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy. |
title_full_unstemmed | Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy. |
title_short | Proceedings: Cell mediated cytotoxicity (CMC) in patients with acute myeloblastic leukaemia receiving immunotherapy. |
title_sort | proceedings: cell mediated cytotoxicity (cmc) in patients with acute myeloblastic leukaemia receiving immunotherapy. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2024885/ https://www.ncbi.nlm.nih.gov/pubmed/1061614 |
work_keys_str_mv | AT taylorgm proceedingscellmediatedcytotoxicitycmcinpatientswithacutemyeloblasticleukaemiareceivingimmunotherapy AT harrisr proceedingscellmediatedcytotoxicitycmcinpatientswithacutemyeloblasticleukaemiareceivingimmunotherapy AT freemancb proceedingscellmediatedcytotoxicitycmcinpatientswithacutemyeloblasticleukaemiareceivingimmunotherapy |